RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
Awarded on September 28, 2026. Full description on SAM.gov.
Overview
- Posted
- September 30, 2026
- Notice type
- Award Notice
- Set-aside
- No Set aside used
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Place of performance
- Washington, District of Columbia, 20024
- PSC
- AB12: R&D- COMMUNITY SVC/DEVELOP: CRIME PREVENTION/CONTROL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
- Award date
- Sep 28, 2026
- Award amount (SAM.gov award notice)
- $340.9M
Identifiers
- Solicitation number
- 75A50126C00010
- Notice ID
- 31ef4ed1358b43d2aaae68a96912297b
- Award number (PIID)
- 75A50126C00010
Description
This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Award Overview
Award Number
75A50126C00010
Award Amount (SAM.gov award notice)
$340.9M
Award Date
Sep 28, 2026
Awardee
Awardee UEI
LBM4GLJNDK31
Awardee CAGE Code
5LVP8
Awardee Address
Glen Allen, VA 23060, UNITED STATES
Original Solicitation
Notice ID: 31ef4ed1358b43d2aaae68a96912297b
Posted Date: Sep 30, 2026
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Lifecycle
- 2Version 2SolicitationArchived
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
- 5Version 5Award NoticeArchivedCurrent
Type changed from Solicitation to Award Notice
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
Similar Opportunities
Additional Details
Solicitation Number
75A50126C00010
Archive Date
Oct 13, 2026
Office Address
WASHINGTON, DC, 20515